This page is dedicated to the Non-systemic Juvenile Idiopathic Arthritis (JIA) research study, one of over 60 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
Professor of Pediatrics, Harvard Medical School
Margaret Chang, MD, PhD
Assistant Professor, Harvard Medical School
Attending Physician, Rheumatology Program
The Non-systemic Juvenile Idiopathic Arthritis (JIA) research study was established in 2025 and is led by Drs. Margaret Chang and Peter Nigrovic.